On Invalid Date, Elanco Animal Health (NYSE: ELAN) reported Q4 2023 earnings per share (EPS) of -$0.29, up 163.64% year over year. Total Elanco Animal Health earnings for the quarter were -$141.00 million. In the same quarter last year, Elanco Animal Health's earnings per share (EPS) was -$0.11.
As of Q2 2024, Elanco Animal Health's earnings has grown year over year. Elanco Animal Health's earnings in the past year totalled -$1.23 billion.
What is ELAN's earnings date?
Elanco Animal Health's earnings date is Invalid Date. Add ELAN to your watchlist to be reminded of ELAN's next earnings announcement.
What was ELAN's revenue last quarter?
On Invalid Date, Elanco Animal Health (NYSE: ELAN) reported Q4 2023 revenue of $1.04 billion up 5.08% year over year. In the same quarter last year, Elanco Animal Health's revenue was $985.00 million.
What was ELAN's revenue growth in the past year?
As of Q2 2024, Elanco Animal Health's revenue has grown 0.14% year over year. This is 10.05 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 10.18%. Elanco Animal Health's revenue in the past year totalled $4.42 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.